These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 12584678

  • 1. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM, Boeckh A, Boothe HW, Wilkie S, Jones S.
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK.
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 4. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
    Bidgood TL, Papich MG.
    J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G, Intorre L, Bertini S, Soldani G.
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
    Davis JL, Foster DM, Papich MG.
    J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs.
    Walker RD, Stein GE, Hauptman JG, MacDonald KH.
    Am J Vet Res; 1992 Dec; 53(12):2315-9. PubMed ID: 1335707
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares.
    Papich MG, Van Camp SD, Cole JA, Whitacre MD.
    J Vet Pharmacol Ther; 2002 Oct; 25(5):343-50. PubMed ID: 12423224
    [Abstract] [Full Text] [Related]

  • 13. Concentration of enrofloxacin and its metabolite ciprofloxacin in canine matrices of the locomotor system.
    Ehinger AM, Meyer-Lindenberg A, Vick M, Nolte I, Kietzmann M.
    J Vet Med A Physiol Pathol Clin Med; 2002 Mar; 49(2):99-104. PubMed ID: 11958474
    [Abstract] [Full Text] [Related]

  • 14. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
    Soliman GA.
    Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.
    Küng K, Riond JL, Wanner M.
    J Vet Pharmacol Ther; 1993 Dec; 16(4):462-8. PubMed ID: 8126763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
    Peyrou M, Bousquet-Melou A, Laroute V, Vrins A, Doucet MY.
    J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
    [Abstract] [Full Text] [Related]

  • 19. Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs.
    Boeckh A, Boothe D, Wilkie S, Jones S.
    Vet Ther; 2001 Oct; 2(4):334-44. PubMed ID: 19746656
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and residues of enrofloxacin in chickens.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Bringas P, Martínez MA, Fernàndez-Cruz ML, Fernández MC, Fernández R.
    Am J Vet Res; 1995 Apr; 56(4):501-6. PubMed ID: 7785830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.